BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34571287)

  • 1. National trends in testing for hepatitis C virus in licensed opioid treatment programs: Differences by facility ownership and state medicaid expansion status.
    Pro G; Tompkins DA; Azari S; Zaller N
    Drug Alcohol Depend; 2021 Nov; 228():109092. PubMed ID: 34571287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailoring services in opioid treatment programs for patients involved in America's criminal justice system: national associations and variation by state and Medicaid expansion status.
    Pro G; Montgomery BEE; Zaller N
    Subst Abuse Treat Prev Policy; 2021 Jun; 16(1):50. PubMed ID: 34147098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicaid Expansion and Availability of Opioid Medications in the Specialty Substance Use Disorder Treatment System.
    Abraham AJ; Yarbrough CR; Harris SJ; Adams GB; Andrews CM
    Psychiatr Serv; 2021 Feb; 72(2):148-155. PubMed ID: 33267651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Workforce Diversity and disparities in wait time and retention among opioid treatment programs.
    Guerrero EG; Kong Y; Frimpong JA; Khachikian T; Wang S; D'Aunno T; Howard DL
    Subst Abuse Treat Prev Policy; 2022 Nov; 17(1):74. PubMed ID: 36384761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of Medicare coverage in opioid treatment programs: Findings from the first three years.
    Abraham AJ; Harris SJ; Yarbrough CR
    J Subst Use Addict Treat; 2024 Mar; 158():209247. PubMed ID: 38072386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Care Integration for Hepatitis C Virus Treatment Through Facilitated Telemedicine Within Opioid Treatment Programs: Qualitative Study.
    Dickerson SS; George SJ; Ventuneac A; Dharia A; Talal AH
    J Med Internet Res; 2024 Jun; 26():e53049. PubMed ID: 38865703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Medicaid expansion on use of opioid agonist treatment and the role of provider capacity constraints.
    Gertner AK; Robertson AG; Jones H; Powell BJ; Silberman P; Domino ME
    Health Serv Res; 2020 Jun; 55(3):383-392. PubMed ID: 32166761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicaid Hepatitis C Virus Treatment Policies: Impact on Testing and Treatment in the Commercially Insured.
    Epstein RL; Wang J; White LF; Kapadia SN; Morgan JR; Bao Y; Linas BP
    Am J Prev Med; 2022 Sep; 63(3):e87-e98. PubMed ID: 35725599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C testing in substance use disorder treatment: the role of program managers in adoption of testing services.
    Frimpong JA; D'Aunno T
    Subst Abuse Treat Prev Policy; 2016 Apr; 11():13. PubMed ID: 27036115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and current clinical practices of opioid treatment programs in the United States.
    Jones CM; Byrd DJ; Clarke TJ; Campbell TB; Ohuoha C; McCance-Katz EF
    Drug Alcohol Depend; 2019 Dec; 205():107616. PubMed ID: 31678836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C Virus Screening among Medicaid-Insured Individuals with Opioid Use Disorder across Substance Use Disorder Treatment Settings.
    Choi S; Healy S; Shapoval L; Forthal S; Neighbors CJ
    Subst Use Misuse; 2021; 56(2):258-263. PubMed ID: 33345680
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of Testing for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Among Medicaid Enrollees Treated With Medications for Opioid Use Disorder in 11 States, 2016-2019.
    Ahrens K; Sharbaugh M; Jarlenski MP; Tang L; Allen L; Austin AE; Barnes AJ; Burns ME; Clark S; Zivin K; Mack A; Liu G; Mohamoud S; McDuffie MJ; Hammerslag L; Gordon AJ; Donohue JM;
    Clin Infect Dis; 2023 May; 76(10):1793-1801. PubMed ID: 36594172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What Explains Changes in Availability of Specialty Mental Health Services in Organized Settings?
    Newton H; Humensky J; Goldman H; Busch SH
    Milbank Q; 2022 Dec; 100(4):1166-1191. PubMed ID: 36575952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing Barriers to On-site HIV and HCV Testing Services in Methadone Maintenance Treatment Programs in the United States: Findings From a National Multisite Qualitative Study.
    Behrends CN; Kapadia SN; Schackman BR; Frimpong JA
    J Public Health Manag Pract; 2021 Jul-Aug 01; 27(4):393-402. PubMed ID: 33346582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study protocol for Project I-Test: a cluster randomized controlled trial of a practice coaching intervention to increase HIV testing in substance use treatment programs.
    Frimpong JA; Parish CL; Feaster DJ; Gooden LK; Nelson MC; Matheson T; Siegel K; Haynes L; Linas BP; Assoumou SA; Tross S; Kyle T; Liguori TK; Toussaint O; Annane D; Metsch LR
    Trials; 2023 Sep; 24(1):609. PubMed ID: 37749635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of State Medicaid Expansions in Integrating Comprehensive Mental Health Services into Opioid Treatment Programs: Differences Across the Rural/Urban Continuum.
    Pro G; Giano Z; Camplain R; Haberstroh S; Camplain C; Wheeler D; Hubach RD; Baldwin JA
    Community Ment Health J; 2021 Aug; 57(6):1017-1022. PubMed ID: 33033972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral Hepatitis and Human Immunodeficiency Virus Testing and Linkage to Care for Individuals Enrolled in an Opioid Treatment Program.
    Rowan SE; Kamis KF; Beum R; Bryan K; Gawenus L; Colon Sanchez D; Hurley H
    J Infect Dis; 2020 Sep; 222(Suppl 5):S384-S391. PubMed ID: 32877565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do patients at high risk for Hepatitis C receive recommended testing? A retrospective cohort study of statewide Medicaid claims linked with OneFlorida clinical data.
    Mkuu RS; Shenkman EA; Muller KE; Huo T; Salloum RG; Cabrera R; Zarrinpar A; Thomas E; Szurek SM; Nelson DR
    Medicine (Baltimore); 2021 Dec; 100(50):e28316. PubMed ID: 34918711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Individual and Community Factors With Hepatitis C Infections Among Pregnant People and Newborns.
    Patrick SW; Dupont WD; McNeer E; McPheeters M; Cooper WO; Aronoff DM; Osmundson S; Stein BD
    JAMA Health Forum; 2021 Oct; 2(10):e213470. PubMed ID: 35977167
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.